Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01114191 · ClinicalTrials.gov registry record · Phase 1
A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Linifanib (ABT-869)
A Phase 1 study, sponsored by Abbott.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT01114191 is a Phase 1 study that has completed, run by Abbott. The registered enrollment target is 12 participants.
The verdict
NCT01114191, a Phase 1 study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
This is a phase 1, open-label study designed to determine the interaction of ketoconazole with ABT-869.
Interventions
- DRUG ketoconazole
- DRUG ABT-869
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2010-05 |
| Est. Completion | 2011-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01114191
The ClinicalTrials.gov registry entry for NCT01114191 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ketoconazole is the first listed.
NCT01114191 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01114191 about?
NCT01114191 is a clinical study titled "A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Linifanib (ABT-869)". This is a phase 1, open-label study designed to determine the interaction of ketoconazole with ABT-869.
What is the current status of trial NCT01114191?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2010-05. Estimated completion is 2011-02.
What interventions are being tested in trial NCT01114191?
The interventions under investigation include: ketoconazole (DRUG), ABT-869 (DRUG).
Who is sponsoring clinical trial NCT01114191?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.